The updated nomenclature recategorizes IDH-mutant glioblastoma (GBM) without a 1p/19q co-deletion under the umbrella of IDH-mutant astrocytoma that may be classified as WHO grade 2–4 depending on further molecular profiling. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).